WVCTSI has announced the formation of an intensive writing group designed for investigators interested in developing National Institutes of Health (NIH) R03 applications. This five-week intensive writing group will begin in May and offers participants the opportunity to receive structured guidance and feedback on their application for the June 2018 submission deadline.
R03 research grants support a variety of projects including pilot or feasibility studies, collection of preliminary data, secondary analysis of existing data, small self-contained research projects, development of new research technology, and more.
Interested participants should visit the program webpage for additional information and complete application instructions. Applications must be submitted by 5 p.m. EST on Monday, April 16. Please email Joan Lakoski, Ph.D., WVCTSI director of proposal development, for more information
WVU professor of Occupational and Environmental Health Sciences recently spoke with Public News Service about the cancellation of a study investigating the health impacts of mountaintop removal and other surface mining. Read the full story online.
Cervical cancer can be insidious. Changes to the cervix are often detected with a pap smear, but for those with limited access to health care, cervical and vaginal cancers can go unnoticed for years—silently growing, spreading and invading other organs—and by the time they’re detected, they may be so advanced that the patient’s prognosis is poor and her treatment options few. Valerie Galvan Turner, a gynecologic oncologist at the West Virginia University Cancer Institute, has opened a randomized clinical trial to assess whether a novel supplemental treatment can help chemotherapy and radiation fight these dangerous forms of cancer better.